ABOS vs. AVR
ABOS (Acumen Pharmaceuticals, Inc.) and AVR (Anteris Technologies Global Corp) are both stocks. Both are in the Healthcare sector — ABOS in Biotechnology, AVR in Medical Instruments & Supplies. Over the past year, ABOS returned 114.02% vs 103.59% for AVR. At a 0.18 correlation, their price movements are largely independent.
Performance
ABOS vs. AVR - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ABOS achieves a 8.53% return, which is significantly lower than AVR's 93.39% return.
ABOS
- 1D
- 0.00%
- 1M
- -9.13%
- YTD
- 8.53%
- 6M
- 15.66%
- 1Y
- 114.02%
- 3Y*
- -22.66%
- 5Y*
- —
- 10Y*
- —
AVR
- 1D
- 7.82%
- 1M
- 55.90%
- YTD
- 93.39%
- 6M
- 112.56%
- 1Y
- 103.59%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
ABOS vs. AVR - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
ABOS Acumen Pharmaceuticals, Inc. | 8.53% | 22.67% | -15.27% |
AVR Anteris Technologies Global Corp | 93.39% | -10.57% | -0.36% |
Correlation
The correlation between ABOS and AVR is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.17 |
Correlation (All Time) Calculated using the full available price history since Dec 16, 2024 | 0.18 |
Fundamentals
ABOS:
-$1.85
AVR:
-$5.33
ABOS:
$0.00
AVR:
$1.85M
ABOS:
-$45.00K
AVR:
$1.38M
ABOS:
-$111.50M
AVR:
-$69.11M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ABOS vs. AVR — Risk / Return Rank
ABOS
AVR
ABOS vs. AVR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Acumen Pharmaceuticals, Inc. (ABOS) and Anteris Technologies Global Corp (AVR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ABOS | AVR | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.02 | ||
| Sortino ratioReturn per unit of downside risk | +0.05 | ||
| Omega ratioGain probability vs. loss probability | 1.24 | 1.23 | +0.01 |
| Calmar ratioReturn relative to maximum drawdown | 3.22 | 2.23 | +0.99 |
| Martin ratioReturn relative to average drawdown | 6.56 | 4.43 | +2.13 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| ABOS | AVR | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.32 | 1.30 | +0.02 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.37 | 0.49 | -0.85 |
Drawdowns
ABOS vs. AVR - Drawdown Comparison
The maximum ABOS drawdown since its inception was -95.56%, which is greater than AVR's maximum drawdown of -71.46%. Use the drawdown chart below to compare losses from any high point for ABOS and AVR.
Loading charts...
Drawdown Indicators
| ABOS | AVR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.56% | -71.46% | -24.10% |
Max Drawdown (1Y)Largest decline over 1 year | -35.61% | -46.77% | +11.16% |
Max Drawdown (3Y)Largest decline over 3 years | -90.73% | — | — |
Current DrawdownCurrent decline from peak | -88.71% | 0.00% | -88.71% |
Average DrawdownAverage peak-to-trough decline | -77.26% | -37.21% | -40.05% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 17.44% | 23.47% | -6.03% |
Volatility
ABOS vs. AVR - Volatility Comparison
The current volatility for Acumen Pharmaceuticals, Inc. (ABOS) is 17.67%, while Anteris Technologies Global Corp (AVR) has a volatility of 20.67%. This indicates that ABOS experiences smaller price fluctuations and is considered to be less risky than AVR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ABOS | AVR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 17.67% | 20.67% | -3.00% |
Volatility (6M)Calculated over the trailing 6-month period | 55.85% | 49.58% | +6.27% |
Volatility (1Y)Calculated over the trailing 1-year period | 86.94% | 80.07% | +6.87% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 97.19% | 93.47% | +3.72% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 97.19% | 93.47% | +3.72% |
Dividends
ABOS vs. AVR - Dividend Comparison
Neither ABOS nor AVR has paid dividends to shareholders.
Financials
ABOS vs. AVR - Financials Comparison
This section allows you to compare key financial metrics between Acumen Pharmaceuticals, Inc. and Anteris Technologies Global Corp. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ABOS and AVR have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AVR has higher volatility (20.67%) compared to ABOS (17.67%). In terms of maximum drawdown, ABOS dropped -95.56% vs AVR's -71.46%.
ABOS currently has the higher Sharpe Ratio (1.32 vs 1.30), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ABOS and AVR
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer